Cases & Deals

Funds managed by Invesco Asset Management Limited invest in Gelesis

Clients Invesco Asset Management Limited

Jones Day advised Invesco Asset Management Limited in connection with its equity investment in Gelesis, Inc., a clinical stage biotechnology company focused on the development of first-in-class products to safely induce weight loss and improve glycemic control.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.